iRadimed IRMD G&A
G&A at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about iRadimed's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is iRadimed's G&A?
- iRadimed (IRMD) reported G&A of $4.57M in Q1 2026.
- How has iRadimed's G&A changed year-over-year?
- iRadimed's G&A decreased by 0.9% year-over-year, from $4.61M to $4.57M.
- What is the long-term trend for iRadimed's G&A?
- Over 4 years (2021 to 2025), iRadimed's G&A has grown at a 16.1% compound annual growth rate (CAGR), from $9.77M to $17.78M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.